Search Clinical Trials

589,087 trials

NCT07646171
Recruiting
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Tel-Aviv Sourasky Medical Center
NCT07646236
CompletedNot Applicable
Gamification Versus E-Learning for Electrocardiogram EducationTaiwan Municipal An-Nan Hospital-China Medical University
NCT07644442
CompletedPhase 1
Study on [14C]HMPL-453（FGFR Inhibitor） in Healthy Chinese Adult Male SubjectsHutchmed
NCT07644936
Not Yet Recruiting
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
NCT07646535
Not Yet RecruitingPhase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.
NCT07644130
Not Yet RecruitingNot Applicable
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere University
NCT07644143
Not Yet RecruitingNot Applicable
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical University
NCT07645157
RecruitingPhase 2
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital of Chongqing Medical University
NCT07646548
Not Yet RecruitingPhase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron Pharmaceuticals
NCT07644481
Not Yet RecruitingNot Applicable
Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete RemissionInstitute of Hematology & Blood Diseases Hospital, China
NCT07645118
Not Yet RecruitingPhase 2
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te Vuong
NCT07645248
Not Yet RecruitingPhase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKline
NCT07643909
Not Yet RecruitingNot Applicable
Health-Related Social Needs Food Boxes Delivery ProgramBoston Medical Center
NCT07645664
Not Yet RecruitingNot Applicable
Scar Management Through Serial CastingCentre hospitalier de l'Université de Montréal (CHUM)
NCT07644533
Not Yet RecruitingNot Applicable
Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced CancerAffiliated Hospital of Qinghai University
NCT07644780
CompletedNot Applicable
Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Maternal Multiple Micronutrients SupplementsNutrition International
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07646028
Not Yet RecruitingPhase 1
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLC
NCT07643779
Not Yet Recruiting
Symptom Severity, Posture, Pain, and Physical Activity in Gastroesophageal Reflux DiseaseKarabuk University
NCT07645976
Completed
Home Environmental Risks and Caregiver AwarenessMarmara University Pendik Training and Research Hospital